AMS

AIVI · Weight decrease · 2d

Currently trading at $1.45, AMS is positioned at 48% of its 52-week high, having returned -30.6% over 90 days and -40.3% over one year, despite a recent 7.4% uptick in 30 days. This price action, showing a stock near its 52-week low ($1.29) and a prolonged downturn, initially aligns with AIVI's mandate to identify international developed-market value stocks. However, AIVI's AI-driven selection, operating within its value-factor pool, appears to be signaling a reduced conviction in AMS. The detected pattern of consecutive weight decreases, from 0.3723% to 0.3511% during the first two weeks of July, suggests the AI has identified either diminishing value potential or more compelling opportunities elsewhere among its roughly 100 international holdings. Even with AMS's recent 30-day gain, the system chose to reduce its allocation across several trading days in July, indicating that the AI's re-evaluation of this Health Care sector constituent is leading to a systematic reduction of exposure at these price levels.

weight 0.360% → 0.351% (-0.009 pp)·stock down 4.8% in the 30 days before

Jul 14·entry $1.39·now $1.47

AIVI · Weight decrease · 2d

The allocation to American Shared Hospital Services (AMS) within the AIVI portfolio recently showed a gradual, consecutive weight decrease, moving from 0.3711% to 0.3616% between June 16 and June 22. This subtle adjustment by WisdomTree’s AI-managed international value ETF suggests a continuous re-evaluation of AMS's standing in its developed-market value-factor pool. Despite AMS registering a 12.9% return over the prior 30 days, its longer-term performance, with declines of 25.5% over 90 days and 33.3% over one year, and a current price of $1.58 still 52% below its 52-week high, likely prompted the AI to find more compelling international value opportunities or to manage perceived risk within its holdings.

weight 0.379% → 0.370% (-0.009 pp)·stock up 8.2% in the 30 days before

Jun 30·entry $1.58·now $1.47

AIVI · Weight decrease · 3d

American Shared Hospital Services (AMS) is currently trading at $1.42, sitting at 47% of its 52-week high, after experiencing a -45.2% decline over the past year and a -30.0% drop in the last 30 days. Despite this substantial price depreciation, which might typically signal value opportunities, WisdomTree's AIVI fund has exhibited a consecutive weight decrease in AMS within its portfolio, moving from 0.3841% to 0.3616% during June. This sustained reduction suggests AIVI's AI-driven selection process, which focuses on international developed-market value stocks, is actively re-evaluating AMS. Even with the stock trading near its 52-week low at $1.42, the AI's model likely indicates the Health Care company no longer satisfies the fund's specific value criteria, prompting de-allocation during its periodic rebalancing cycles.

weight 0.374% → 0.362% (-0.012 pp)·stock up 6.8% in the 30 days before

Jun 22·entry $1.42·now $1.47

AIVI · Weight decrease · 2d

AIVI's portfolio adjustment for AMS shows a prevailing pattern of weight reduction across the observed period, characterized by several consecutive decreases, though interspersed with minor positive adjustments. The AI-driven process, managing a portfolio of international developed-market value stocks, appears to be making calibrated, multi-day adjustments to its holding in this healthcare company. Despite AMS's current price of $1.46, trading near its 52-week low after a -38.1% one-year return, the sustained negative price momentum likely prompted the AI to re-evaluate its value proposition. These stepped reductions, moving from 0.3961% to 0.3668% over the period, suggest the AI is systematically trimming exposure, interpreting the prolonged decline as eroding fundamental value or increased risk rather than an enhanced buying opportunity within its international value mandate.

weight 0.374% → 0.367% (-0.007 pp)·stock up 9.0% in the 30 days before

Jun 18·entry $1.46·now $1.47

AIVI · Weight decrease · 4d

Trading at $1.46, AMS currently sits at 48% of its 52-week high, reflecting a 90-day return of -30.5% and a 1-year return of -39.4%, despite a recent 30-day gain of +0.7%. This sustained depreciation likely prompted AIVI's AI, which selects within a developed-international value-factor pool, to reassess AMS's eligibility or optimal weighting. Operating with an international value + AI overlay strategy, the system's consecutive weight decreases from 0.4096% on June 1st to 0.3631% on June 11th indicate a systematic re-evaluation. The AI's models, considering AMS's price trajectory against its internal value metrics, determined a reduced allocation was appropriate within the fund's periodic rebalancing structure. This move suggests the AI no longer perceived the stock to meet its evolving value or risk criteria as favorably within its specific international mandate.

weight 0.399% → 0.363% (-0.036 pp)·stock down 15.6% in the 30 days before

Jun 11·entry $1.46·now $1.47

AIVI · Weight decrease · 3d

AMS, currently trading at $1.47, sits at 48% of its 52-week high of $3.04. This price reflects a 31.0% decline over 90 days and a 39.0% drop over the past year, despite a recent 9.7% 30-day gain. AIVI, employing an AI overlay within an international developed-market value-factor pool, appears to be reassessing its position in this Health Care company. The AI has implemented a series of reductions in AMS's weight, notably from 0.4013% on June 2nd to 0.3799% by June 10th, with a string of decreases observed from June 5th onward. This pattern suggests the AI’s model may perceive a deteriorating value proposition for AMS, despite its current low price relative to its 52-week range, or has identified more compelling value opportunities among the other ~100 stocks in its portfolio. The fund's AI-driven approach to this comparatively underserved international value segment is likely adjusting exposure as the AI's internal metrics shift for AMS.

weight 0.399% → 0.380% (-0.019 pp)·stock down 22.2% in the 30 days before

Jun 10·entry $1.47·now $1.47

AIVI · Weight decrease · 2d

AIVI has adjusted its position in AMS with a series of minor weight reductions, decreasing from 0.3988% to 0.3841% over several trading days in early June. This gradual scaling back occurs even as AMS recorded a 12.8% gain over 30 days, contrasting with its 90-day and 1-year returns showing declines of 29.2% and 37.2%, respectively, and trading near its 52-week low of $1.29. For an AI-managed fund prioritizing international developed-market value, this movement indicates the system is likely re-evaluating AMS’s risk-adjusted value proposition. The AI overlay, operating within WisdomTree’s periodic rebalancing framework, appears to perceive the recent short-term price appreciation as insufficient to maintain the prior weighting, or it is identifying other international value opportunities with more compelling profiles.

weight 0.399% → 0.384% (-0.015 pp)·stock down 35.3% in the 30 days before

Jun 8·entry $1.30·now $1.47

AIVI · Weight decrease · 2d

weight 0.410% → 0.387% (-0.022 pp)·stock down 25.5% in the 30 days before

Jun 3·entry $1.37·now $1.47

AIVI · Weight decrease · 2d

The AI ETF is likely reducing its AMS exposure due to its models detecting deteriorating short-term fundamental outlook, negative sentiment, or a shift in sector-specific risks for Amadeus IT Group, leading to a systematic de-risking. This sustained decrease indicates the AI is reallocating capital to assets with better perceived growth potential or lower risk profiles. For retail investors, this pattern underscores the importance of consistent portfolio monitoring and recognizing that even minor, persistent weight adjustments by sophisticated algorithms can signal a fundamental shift in a company's prospects. It serves as a prompt to investigate the underlying reasons for such changes rather than simply holding or adding to a declining asset without further due diligence.

weight 0.378% → 0.369% (-0.009 pp)·stock down 26.0% in the 30 days before

Apr 29·entry $1.34·now $1.47